Astrazeneca AZN
NYSE AZN
$164.56 -0.37 (-0.22%)
At close: Aug 20, 2026 · 4:00 PM EDT

Astrazeneca (AZN) EBIT Margin (2009 - 2026)

Astrazeneca (AZN) posted quarterly EBIT Margin of 20.57% for Q2 2026, down 370.0% year-over-year from 7.62% in Q2 2025, and down 99.63% quarter-over-quarter from 5514.29% in Q1 2026.

Astrazeneca (AZN) EBIT Margin (2009 - 2026) Analysis & Trends

Astrazeneca's EBIT Margin history runs 18 years deep, the most recent figure standing at 20.57% for Q2 2026.

  • In Q2 2026, EBIT Margin fell 370.0% year-over-year to 20.57%; the TTM figure through Jun 2026 stood at 90.26% (up 1675.0% YoY), while the FY2025 annual figure was 23.4%, up 490.0% from the prior year.
  • EBIT Margin for Q2 2026 stood at 20.57%, down from 5514.29% in the prior quarter.
  • The five-year high for EBIT Margin was 68650.0% in Q2 2024, with the low at 20.57% in Q2 2026.
  • The 5-year median for EBIT Margin is 2882.38% (2023), against an average of 11540.91%.
  • The sharpest annual moves came in 2024 and 2025: EBIT Margin jumped 6737746 bps in 2024, then sank 6862573 bps in 2025.
  • Astrazeneca's EBIT Margin stood at 1685.44% in 2022, then jumped by 30 bps to 2195.27% in 2023, then plunged by 89 bps to 249.82% in 2024, then surged by 19768 bps to 49633.33% in 2025, then tumbled by 100 bps to 20.57% in 2026.
  • Business Quant data shows AZN's EBIT Margin at 20.57% in Q2 2026, 5514.29% in Q1 2026, and 49633.33% in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 28.21%
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn 37.86%
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -3.52%
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn 32.97%
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 20.57%
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn 34.95%
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -133.21%
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn 28.37%
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 5.72%
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 124.39%

Historic Data

Download Data
DateValue
Jun 30, 2026 20.57%
Mar 31, 2026 5,514.29%
Dec 31, 2025 49,633.33%
Sep 30, 2025 32,572.73%
Jun 30, 2025 24.27%
Mar 31, 2025 4,964.86%
Dec 31, 2024 249.82%
Sep 30, 2024 3,569.49%
Jun 30, 2024 68,650.00%
Mar 31, 2024 6,922.22%
Dec 31, 2023 2,195.27%
Sep 30, 2023 2,014.43%
Jun 30, 2023 1,272.54%
Mar 31, 2023 9,440.74%
Dec 31, 2022 1,685.44%
Sep 30, 2022 699.44%
Jun 30, 2022 17,966.67%
Mar 31, 2022 340.31%
Dec 31, 2021 -56.92%
Sep 30, 2021 -1,339.20%